Drug Makers Protest Plan on Legal Costs - WSJ.com

Drug Makers Protest Plan on Legal Costs - WSJ.com: "Six leading drug makers sent a letter Friday to accounting-rule lawmakers, objecting to a proposed rule that would require companies to disclose estimated costs of all continuing litigation. Providing such an estimate would be futile, costly and unlikely to provide meaningful information for investors, they said."